연구동향 분석

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

임호영 박준오 김종석 오도연 Chiun Hsu Jen-Shi Chen Li-Tzong Chen Mauro Orlando 2015년

논문상세정보
인용/피인용
' Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • biliarytractneoplasms
  • cholangiocarcinoma
  • cisplatin
  • gallbladder neoplasms
  • gemcitabine
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,404 0

0.0%

' Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review' 의 참고문헌

  • Systemic therapy for biliary tract cancers
    Hezel AF Oncologist 13 : 415 ~ 423 [2008]
  • Systemic therapy for biliary tract cancers
    Hezel AF Oncologist 13 415-423 [2008]
  • Role of low dose prolonged infusion of gemcitabine and cisplatin in inoperable carcinoma gallbladder: a prospective pilot study
    Singh D Ann Oncol 22 : v83 ~ [2011]
  • Role of low dose prolonged infusion of gemcitabine and cisplatin in inoperable carcinoma gallbladder: a prospective pilot study
    Singh D Ann Oncol 22 v83- [2011]
  • Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
    Heinemann V J Clin Oncol 24 : 3946 ~ 3952 [2006]
  • Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
    Heinemann V J Clin Oncol 24 3946-3952 [2006]
  • Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma
    Kang MJ Acta Oncol 51 : 860 ~ 866 [2012]
  • Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma
    Kang MJ Acta Oncol 51 860-866 [2012]
  • Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy
    Park I Cancer 115 : 4148 ~ 4155 [2009]
  • Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy
    Park I Cancer 115 4148-4155 [2009]
  • Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer
    Meyerhardt JA Dig Dis Sci 53 : 564 ~ 570 [2008]
  • Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer
    Meyerhardt JA Dig Dis Sci 53 564-570 [2008]
  • Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
    Lee J Cancer Chemother Pharmacol 61 : 47 ~ 52 [2008]
  • Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
    Lee J Cancer Chemother Pharmacol 61 47-52 [2008]
  • Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Park BK J Gastroenterol Hepatol 21 : 999 ~ 1003 [2006]
  • Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Park BK J Gastroenterol Hepatol 21 999-1003 [2006]
  • Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
    Thongprasert S Ann Oncol 16 : 279 ~ 281 [2005]
  • Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
    Thongprasert S Ann Oncol 16 279-281 [2005]
  • Pancreatic adenocarcinoma:ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Seufferlein T Ann Oncol 23 (Suppl 7) : 33 ~ 40 [2012]
  • Pancreatic adenocarcinoma:ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Seufferlein T Ann Oncol 23 Suppl 7 33-40 [2012]
  • New and emerging treatment options for biliary tract cancer
    Noel MS Onco Targets Ther 6 : 1545 ~ 1552 [2013]
  • New and emerging treatment options for biliary tract cancer
    Noel MS Onco Targets Ther 6 1545-1552 [2013]
  • Meta analysis of oxaliplatinbased combination chemotherapy for advanced gallbladder and bile duct cancers (AGBC)
    Thatikonda C Am J Gastroenterol 105 : S72 ~ [2010]
  • Meta analysis of oxaliplatinbased combination chemotherapy for advanced gallbladder and bile duct cancers (AGBC)
    Thatikonda C Am J Gastroenterol 105 S72- [2010]
  • Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
    Bridgewater J J Hepatol 60 : 1268 ~ 1289 [2014]
  • Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
    Bridgewater J J Hepatol 60 1268-1289 [2014]
  • Gemzar (gemcitabine for injection) [prescribing information]
    Eli Lilly and Company; [2013]
  • Gemzar (gemcitabine for injection) [prescribing information]
    - [2013]
  • Gemcitabine with carboplatin for advanced biliary tract cancers : a phase II single institution study
    Williams KJ HPB(Oxford) 12 : 418 ~ 426 [2010]
  • Gemcitabine with carboplatin for advanced biliary tract cancers : a phase II single institution study
    Williams KJ HPB(Oxford) 12 418-426 [2010]
  • Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer : a multicentre, open-label, randomised, phase 3 study
    Lee J Lancet Oncol 13 : 181 ~ 188 [2012]
  • Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer : a multicentre, open-label, randomised, phase 3 study
    Lee J Lancet Oncol 13 181-188 [2012]
  • Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)
    Giuliani F Ann Oncol 17 (Suppl 7) : 73 ~ 77 [2006]
  • Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)
    Giuliani F Ann Oncol 17 Suppl 7 73-77 [2006]
  • Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer : a comparative multicentre study in Japan
    Okusaka T Br J Cancer 103 : 469 ~ 474 [2010]
  • Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer : a comparative multicentre study in Japan
    Okusaka T Br J Cancer 103 469-474 [2010]
  • Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study. The UK ABC-01 Study
    Valle JW Br J Cancer 101 : 621 ~ 627 [2009]
  • Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study. The UK ABC-01 Study
    Valle JW Br J Cancer 101 621-627 [2009]
  • Gallbladder cancer, a different disease that needs individual trials
    Gallardo J J Clin Oncol 23 : 7753 ~ 7754 [2005]
  • Gallbladder cancer, a different disease that needs individual trials
    Gallardo J J Clin Oncol 23 7753-7754 [2005]
  • Gallbladder cancer : epidemiology and outcome
    Hundal R Clin Epidemiol 6 : 99 ~ 109 [2014]
  • Gallbladder cancer : epidemiology and outcome
    Hundal R Clin Epidemiol 6 99-109 [2014]
  • Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
    Goldstein D Cancer Chemother Pharmacol 67 : 519 ~ 525 [2011]
  • Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
    Goldstein D Cancer Chemother Pharmacol 67 519-525 [2011]
  • Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
    Charoentum C World J Gastroenterol 13 : 2852 ~ 2854 [2007]
  • Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
    Charoentum C World J Gastroenterol 13 2852-2854 [2007]
  • Epidemiology of biliary tract cancers : an update
    Randi G Ann Oncol 20 : 146 ~ 159 [2009]
  • Epidemiology of biliary tract cancers : an update
    Randi G Ann Oncol 20 146-159 [2009]
  • Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome : a phase 2 study
    Zhu AX Lancet Oncol 11 : 48 ~ 54 [2010]
  • Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome : a phase 2 study
    Zhu AX Lancet Oncol 11 48-54 [2010]
  • Does gemcitabinebased combination therapy improve the prognosis of unresectable pancreatic cancer?
    Sun C World J Gastroenterol 18 : 4944 ~ 4958 [2012]
  • Does gemcitabinebased combination therapy improve the prognosis of unresectable pancreatic cancer?
    Sun C World J Gastroenterol 18 4944-4958 [2012]
  • Current status of chemotherapy for the treatment of advanced biliary tract cancer
    Takashi Sasaki The Korean Journal of Internal Medicine 28 (5) : 515 ~ 524 [2013]
  • Current status of chemotherapy for the treatment of advanced biliary tract cancer
    Takashi Sasaki The Korean Journal of Internal Medicine 28 5 515-524 [2013]
  • Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma
    Lee GW Am J Clin Oncol 29 : 127 ~ 131 [2006]
  • Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma
    Lee GW Am J Clin Oncol 29 127-131 [2006]
  • Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer
    Valle J N Engl J Med 362 : 1273 ~ 1281 [2010]
  • Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer
    Valle J N Engl J Med 362 1273-1281 [2010]
  • Cisplatin and gemcitabine for advanced biliary tract cancer:a meta-analysis of two randomized trials
    Mizuno N J Clin Oncol 31 (Suppl) : 4120 ~ [2013]
  • Cisplatin and gemcitabine for advanced biliary tract cancer:a meta-analysis of two randomized trials
    Mizuno N J Clin Oncol 31 Suppl 4120- [2013]
  • Cisplatin and gemcitabine for advanced biliary tract cancer : a meta-analysis of two randomised trials
    Valle JW Ann Oncol 25 : 391 ~ 398 [2014]
  • Cisplatin and gemcitabine for advanced biliary tract cancer : a meta-analysis of two randomised trials
    Valle JW Ann Oncol 25 391-398 [2014]
  • Chemotherapy with gemcitabine plus cisplatin in patients with advanced biliary tract carcinoma at Chang Gung Memorial Hospital : a retrospective analysis
    Wu CE Chang Gung Med J 35 : 420 ~ 427 [2012]
  • Chemotherapy with gemcitabine plus cisplatin in patients with advanced biliary tract carcinoma at Chang Gung Memorial Hospital : a retrospective analysis
    Wu CE Chang Gung Med J 35 420-427 [2012]
  • Chemotherapy using gemcitabine (G) plus cisplatin (C) in locally in stage III and IV gallbladder and biliary tract
    Mahfouf H. J Clin Oncol 28 (Suppl) : e14654 ~ [2010]
  • Chemotherapy using gemcitabine (G) plus cisplatin (C) in locally in stage III and IV gallbladder and biliary tract
    Mahfouf H. J Clin Oncol 28 Suppl e14654- [2010]
  • Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma : a retrospective analysis
    Eckmann KR Gastrointest Cancer Res 4 : 155 ~ 160 [2011]
  • Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma : a retrospective analysis
    Eckmann KR Gastrointest Cancer Res 4 155-160 [2011]
  • Chemotherapy in advanced biliary tract carcinoma : a pooled analysis of clinical trials
    Eckel F Br J Cancer 96 : 896 ~ 902 [2007]
  • Chemotherapy in advanced biliary tract carcinoma : a pooled analysis of clinical trials
    Eckel F Br J Cancer 96 896-902 [2007]
  • Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
    Glimelius B Ann Oncol 7 : 593 ~ 600 [1996]
  • Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
    Glimelius B Ann Oncol 7 593-600 [1996]
  • Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer : a phase 2 study
    Gruenberger B Lancet Oncol 11 : 1142 ~ 1148 [2010]
  • Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer : a phase 2 study
    Gruenberger B Lancet Oncol 11 1142-1148 [2010]
  • Biliary tract cancers : current concepts and controversies
    Leonard GD Expert Opin Pharmacother 6 : 211 ~ 223 [2005]
  • Biliary tract cancers : current concepts and controversies
    Leonard GD Expert Opin Pharmacother 6 211-223 [2005]
  • Best supportive care compared with chemotherapy for unresectable gall bladder cancer : a randomized controlled study
    Sharma A J Clin Oncol 28 : 4581 ~ 4586 [2010]
  • Best supportive care compared with chemotherapy for unresectable gall bladder cancer : a randomized controlled study
    Sharma A J Clin Oncol 28 4581-4586 [2010]
  • Attenuated dose of gemcitabine with cisplatin in patients (pts) with unresectable or metastatic biliary tract cancer (ABC): results of single Thai institution
    Charoentum C J Clin Oncol 31 (Suppl 4) : 265 ~ [2013]
  • Attenuated dose of gemcitabine with cisplatin in patients (pts) with unresectable or metastatic biliary tract cancer (ABC): results of single Thai institution
    Charoentum C J Clin Oncol 31 Suppl 4 265- [2013]
  • A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer
    Doval DC Br J Cancer 90 : 1516 ~ 1520 [2004]
  • A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer
    Doval DC Br J Cancer 90 1516-1520 [2004]
  • A phase II study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma
    Julka PK Hepatobiliary Pancreat Dis Int 5 : 110 ~ 114 [2006]
  • A phase II study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma
    Julka PK Hepatobiliary Pancreat Dis Int 5 110-114 [2006]
  • A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer
    Yonemoto N Jpn J Clin Oncol 37 : 843 ~ 851 [2007]
  • A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer
    Yonemoto N Jpn J Clin Oncol 37 843-851 [2007]
  • A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Kim ST Cancer 106 : 1339 ~ 1346 [2006]
  • A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Kim ST Cancer 106 1339-1346 [2006]